Ceftazidime + Sulbactam

Last updated 08 Apr 2021 | 05:55 AM (UTC)

Ceftazidime + Sulbactam Uses

Ceftazidime+Sulbactam is used in the treatment of bacterial infections.

How Ceftazidime + Sulbactam works

Ceftazidime + Sulbactam is a combination of two medicines: Ceftazidime and Sulbactam. Ceftazidime is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Sulbactam is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Ceftazidime against bacteria.

Common side effects of Ceftazidime + Sulbactam

Nausea, Vomiting, Diarrhea, Stomach pain, Increased liver enzymes, Allergic reaction

Want to Know More

Read Our Editorial Policy

Medicine brands for Ceftazidime + Sulbactam

Capsutab Drugs Pvt Ltd

Expert advice for Ceftazidime + Sulbactam

You have been prescribed this combination medicine to treat bacterial infections even if they have developed resistance.
Finish the prescribed course, even if you start to feel better. Stopping it early may make the infection come back and harder to treat.
Diarrhea may occur as a side effect. Taking probiotics along with Ceftazidime + Sulbactam may help. Talk to your doctor if you notice bloody stools or develop abdominal cramps.
Take it with food and plenty of fluids to avoid an upset stomach.
Stop taking Ceftazidime + Sulbactam and inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking it.

Frequently asked questions for Ceftazidime + Sulbactam

Q. How long does Ceftazidime+Sulbactam takes to work?

Usually, Ceftazidime+Sulbactam starts working soon after taking it. However, it may take some days to kill all the harmful bacteria and make you feel better.

Q. What if I don't get better after using Ceftazidime+Sulbactam?

Inform your doctor if you don't feel better after finishing the full course of treatment. Also, inform him if your symptoms are getting worse while using this medicine.